Literature DB >> 15186589

HIV-1 cord-blood seroprevalence of parturient women in Sihanoukville, Cambodia.

T Theng1, P Sok, D Pugatch, J I Harwell, K M Rufner, V Chhi Mean, K H Mayer, S Cu-Uvin.   

Abstract

Facing a 1.2% HIV-1 seroprevalence amongst its adult female population, Cambodia recently established national guidelines for the expansion of services to prevent mother-to-child transmission. Anticipating this expansion, Sihanoukville Hospital performed an anonymous HIV-1 cord-blood serosurvey of 600 consecutive deliveries from May 2001 through June 2002. Laboratory analysis utilizing ELISA and Western blot techniques yielded a 4.2% seroprevalence; a value resembling previous reports from other Sihanoukville antenatal clinics (3.9%) but exceeding the national ANC clinic average of 2.3%. Demographic information was confidentially collected and analysed for co-variation to HIV-1 status. One hundred percent of HIV positive mothers (P =0.013) self-reported the occupation of housewife, consistent with previous documentations suggesting the shift in infection burden from high-risk groups into the general female population. A substantial proportion received no prenatal care, suggesting that interventions addressing mother-to-child transmission will need to prepare for the management of pregnant women presenting at or near the time of delivery.

Entities:  

Mesh:

Year:  2004        PMID: 15186589     DOI: 10.1258/095646204774195290

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  2 in total

Review 1.  Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic review.

Authors:  Michael K Mwaniki; Maurine Atieno; Joy E Lawn; Charles R J C Newton
Journal:  Lancet       Date:  2012-01-13       Impact factor: 79.321

2.  Vaginal douching in Cambodian women: its prevalence and association with vaginal candidiasis.

Authors:  Lon Say Heng; Hiroshi Yatsuya; Satoshi Morita; Junichi Sakamoto
Journal:  J Epidemiol       Date:  2009-12-12       Impact factor: 3.211

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.